Literature DB >> 27444816

A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: An application for bladder cancer treatment.

Marian Vila-Caballer1, Gaia Codolo1, Fabio Munari2, Alessio Malfanti3, Matteo Fassan4, Massimo Rugge4, Anna Balasso3, Marina de Bernard5, Stefano Salmaso6.   

Abstract

Stealth pH-responsive liposomes for the delivery of therapeutic proteins to the bladder epithelium were prepared using methoxy-poly(ethylene glycol)5kDa-1,2-distearoyl-sn-glycero-3-phosphoethanolamine (mPEG5kDa-DSPE) and stearoyl-poly(ethylene glycol)-poly(methacryloyl sulfadimethoxine) copolymer (stearoyl-PEG-polySDM), which possesses an apparent pKa of 7.2. Liposomes of 0.2:0.6:100, 0.5:1.5:100 and 1:3:100 mPEG5kDa-DSPE/stearoyl-PEG-polySDM/(soybean phosphatidylcholine+cholesterol) molar ratios were loaded with bovine serum albumin (BSA) as a protein model. The loading capacity was 1.3% w/w BSA/lipid. At pH7.4, all liposome formulations displayed a negative zeta-potential and were stable for several days. By pH decrease or addition to mouse urine, the zeta potential strongly decreased, and the liposomes underwent a rapid size increase and aggregation. Photon correlation spectroscopy (PCS) and transmission electron microscopy (TEM) analyses showed that the extent of the aggregation depended on the stearoyl-PEG-polySDM/lipid molar ratio. Cytofluorimetric analysis and confocal microscopy showed that at pH6.5, the incubation of MB49 mouse bladder cancer cells and macrophages with fluorescein isothiocyanate-labelled-BSA (FITC-BSA) loaded and N-(Lissamine Rhodamine B sulfonyl)-1, 2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine triethylammonium salt (rhodamine-DHPE) labelled 1:3:100 mPEG5kDa-DSPE/stearoyl-PEG-polySDM/lipid molar ratio liposomes resulted in a time-dependent liposome association with the cells. At pH7.4, the association of BSA-loaded liposomes with the MB49 cells and macrophages was remarkably lower than at pH6.5. Confocal images of bladder sections revealed that 2h after the instillation, liposomes at pH7.4 and control non-responsive liposomes at pH7.4 or 6.5 did not associate nor delivered FITC-BSA to the bladder epithelium. On the contrary, the pH-responsive liposome formulation set at pH6.5 and soon administered to mice by bladder instillation showed that, 2h after administration, the pH-responsive liposomes efficiently delivered the loaded FITC-BSA to the bladder epithelium.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bladder cancer treatment; Protein delivery; Tumour targeting; pH-responsive liposomes

Mesh:

Substances:

Year:  2016        PMID: 27444816     DOI: 10.1016/j.jconrel.2016.07.024

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  15 in total

1.  Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications.

Authors:  Parham Sahandi Zangabad; Soroush Mirkiani; Shayan Shahsavari; Behrad Masoudi; Maryam Masroor; Hamid Hamed; Zahra Jafari; Yasamin Davatgaran Taghipour; Hura Hashemi; Mahdi Karimi; Michael R Hamblin
Journal:  Nanotechnol Rev       Date:  2017-12-12       Impact factor: 7.848

2.  Targeting and Internalization of Liposomes by Bladder Tumor Cells Using a Fibronectin Attachment Protein-Derived Peptide-Lipopolymer Conjugate.

Authors:  Young Lee; Erin Kischuk; Scott Crist; Timothy L Ratliff; David H Thompson
Journal:  Bioconjug Chem       Date:  2017-05-05       Impact factor: 4.774

Review 3.  Advances on Tumor-Targeting Delivery of Cytotoxic Proteins.

Authors:  Akmal M Asrorov; Zeyun Gu; Kyoung Ah Min; Meong Cheol Shin; Yongzhuo Huang
Journal:  ACS Pharmacol Transl Sci       Date:  2019-12-30

Review 4.  Toxic proteins application in cancer therapy.

Authors:  Zahra Setayesh-Mehr; Mahdiye Poorsargol
Journal:  Mol Biol Rep       Date:  2021-04-25       Impact factor: 2.316

5.  Antitumor Effect of Hyperoside Loaded in Charge Reversed and Mitochondria-Targeted Liposomes.

Authors:  Yufei Feng; Guozhao Qin; Shuyuan Chang; Zhongxu Jing; Yanyan Zhang; Yanhong Wang
Journal:  Int J Nanomedicine       Date:  2021-04-28

6.  Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel.

Authors:  Ho Yub Yoon; In Ho Chang; Yoon Tae Goo; Chang Hyun Kim; Tae Hoon Kang; Soo-Yeon Kim; Sang Jin Lee; Seh Hyon Song; Young Mi Whang; Young Wook Choi
Journal:  Int J Nanomedicine       Date:  2019-08-05

Review 7.  Dual-Targeting and Stimuli-Triggered Liposomal Drug Delivery in Cancer Treatment.

Authors:  Nour AlSawaftah; William G Pitt; Ghaleb A Husseini
Journal:  ACS Pharmacol Transl Sci       Date:  2021-06-01

Review 8.  Endogenous pH-responsive nanoparticles with programmable size changes for targeted tumor therapy and imaging applications.

Authors:  Wei Wu; Li Luo; Yi Wang; Qi Wu; Han-Bin Dai; Jian-Shu Li; Colm Durkan; Nan Wang; Gui-Xue Wang
Journal:  Theranostics       Date:  2018-04-30       Impact factor: 11.556

Review 9.  Potential Applications of Nanotechnology in Urological Cancer.

Authors:  Ming-Hui He; Li Chen; Ting Zheng; Yu Tu; Qian He; Hua-Lin Fu; Ju-Chun Lin; Wei Zhang; Gang Shu; Lili He; Zhi-Xiang Yuan
Journal:  Front Pharmacol       Date:  2018-07-09       Impact factor: 5.810

10.  Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.

Authors:  Xuefeng Qiu; Kai Cao; Tingsheng Lin; Wei Chen; Ahu Yuan; Jinhui Wu; Yiqiao Hu; Hongqian Guo
Journal:  Int J Nanomedicine       Date:  2017-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.